Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators

Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators

US Patent 10947596 · Granted Mar 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-R2025
Combination therapy for treatment of LKB1 deficient cancers2024
Compositions and methods of modulating anti-tumor immunity2024
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint in2023
Combination therapy for cancer using bromodomain and extra-terminal (BET) protei2022
Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhib2022
EZH2 inhibitors and uses thereof2022
Methods of using anti-lap antibodies2022
Anti-lap antibody variants2021
Methods of diagnosing and prognosing lung cancer2021
Inhibitors of EGFR and methods of use thereof2020
Combination therapy of transcription inhibitors and kinase inhibitors2020